ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf209 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Hyogon Sohn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Rheumatology and Immunology, Washington University in St Louis, St Louis, MO, United States. Hauptthemen laut MEDLINE: Killer Cells, Natural, Glycolysis, Histones, ATP Citrate (pro-S)-Lyase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Leukemia and Lymphoma Society, CDI Center for Pediatric Immunology.
Abstract (Originalsprache)
Natural killer (NK) cells are innate immune lymphocytes important for host viral and tumor immunity. We investigated the requirement for ATP citrate lyase (ACLY) in NK cell function using an inducible genetic mouse model. ACLY regulates the citrate-malate shuttle, generating cytosolic acetyl-coenzyme A that is primarily used for acetylation or lipid synthesis. ACLY-deficient NK cells upon IL-15 activation exhibited significant defects in glycolysis, proliferation, cytokine production, and cytotoxicity, without decreased intracellular lipids. Notably, ACLY deficiency specifically resulted in reduced NK cell responses to activating receptors associated with the adapter proteins DAP10 or DAP12. This is due to decreased DAP12 and increased DAP10 transcript and protein, coupled with epigenetic profiling that demonstrated altered histone acetylation of these genes in ACLY KO. Supplementation of ACLY-deficient NK cells with acetate was sufficient to overcome most functional defects, including restoring DAP10/12 expression and activating receptor function, emphasizing the importance of ACLY-generated cytosolic acetyl-coenzyme A for NK effector functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Rheumatology and Immunology, Washington University in St Louis, St Louis, MO, United States.
- Department of Medicine, Division of Oncology, Washington University in St Louis, St Louis, MO, United States.
- Department of Pathology and Immunology, Washington University in St Louis, St Louis, MO, United States.
ORCID-Profile: Jennifer Tran, Jacqueline E Payton, Megan A Cooper
Förderung
- NCI NIH HHS
- Leukemia and Lymphoma Society
- CDI Center for Pediatric Immunology
- NIH HHS
- NIAID NIH HHS
- CDI Center for Pediatric Immunology at Washington University in St Louis
- Washington University School of Medicine in St Louis
- Siteman Flow Cytometry
Zitieren
APA
Sohn, H., Kolicheski, A., Poursine-Laurent, J., Tran, J., Wang, Y., Gan, K., Tobin, J. M., Saucier, N., Fehniger, T. A., Payton, J. E., & Cooper, M. A. (2025). ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf209
Vancouver
Sohn H, Kolicheski A, Poursine-Laurent J, Tran J, Wang Y, Gan K, et al. ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf209
BibTeX
@article{Sohn2025,
author = {Sohn, Hyogon and Kolicheski, Ana and Poursine-Laurent, Jennifer and Tran, Jennifer and Wang, Yongjun and Gan, Kelly and Tobin, Joshua M and Saucier, Nermina and Fehniger, Todd A and Payton, Jacqueline E and Cooper, Megan A},
title = {ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf209}
}
EUVIMED